People · Operator
Named in public records as an officer, director or promoter · active 2009–2014 · Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Trientis Vitae, LLC | — | Other | Series B | $26.4M | $438.6M | 2014 |
| Beryllium, LLC | — | Pharmaceuticals | Series A | $11.5M | $232.3M | 2009 |
| DKI Ventures, LLC | — | Other | Series A | $4.3M | $64.3M | 2012 |
Jeffrey Newton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey Newton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Hubbard | 1 | 4 |
| Mirza Cifric | 1 | 3 |
| Lance Stewart | 1 | 2 |
| Neil Weir | 1 | 2 |
| Shahir Kassam-Adams | 1 | 2 |
| M. Dennis Jensen | 1 | 1 |
| David Byerly | 1 | 1 |
| Johan Pontin | 1 | 1 |
| Dean Pernisie | 1 | 1 |
| Brent Bannerman | 1 | 1 |
| Gary McWalters | 1 | 1 |
| Stephen Gerrard | 1 | 1 |
| Charles Ebersole | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.